[Middle Meningeal Artery Embolization for Chronic Subdural Hematoma].

Abstract

Middle meningeal artery embolization(MMAE) is an effective treatment for chronic subdural hematoma(CSDH). Retrospective analyses have indicated that MMAE for CSDH is not only minimally invasive but also highly safe, and is associated with a significantly lower recurrence rate than that of conventional treatments. However, there is no consensus regarding treatment strategies, including the patient-selection criteria, embolic materials, and procedural techniques. Several randomized controlled trials have been conducted to compare conventional treatments with MMAE, and the results indicate that MMAE could potentially constitute a standard treatment option for CSDH in the future.